EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
Active, not recruiting · NCT01591356 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors | Advanced Malignant Solid Neoplasm | Active, not recruiting | Phase 1 | 2026-07-21 | NCT01591356 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M D Anderson Cancer Center | Houston | United States | 667 |